Search results

Selected filters:

Europe
Valuation

Article type

Topic

Sector

Jurisdictions

83 results found for your search

Sort options
21 January 2020

Four trends that will shape life sciences IP deal-making in 2020

After a record-breaking 2019, here are the key value-creation issues to look out for in the new decade

09 January 2020

NPE’s litigation move may be a sign of things to come in the healthcare sector

Move by Parallax Health Sciences is an indication that patent assertion plays could increasingly affect life sciences companies as their use of digital technologies increases

12 December 2019

Seoul Semiconductor patent auction analysis reveals a mixed bag of assets

In sales due to be held this month and next, the Korean company offers two radically different portfolios. But value is in the eye of the beholder - and a range of businesses could be making bids

05 December 2019

Auto IP stakeholders in Asia call for peace, prepare for war

Huawei, Nokia and top Japanese brands discussed the licensing conflicts confronting the industry in front of a packed room in Shanghai

05 December 2019

The search for the world's leading IP strategists is on

IAM is currently seeking nominations for individuals to be considered for the 2020 edition of the Strategy 300 - our unique guide to the men and women who excel in the creation of IP value

26 November 2019

Korean company plans to auction 5G, LED rights

Seoul Semiconductor is kicking off a “new patent management strategy” with two portfolios going under the hammer later this year

14 November 2019

Skyhawk deal with Celgene confirms growing importance of platform technologies in life sciences IP value creation

Increased focus on gene and cell-related therapies as well as falling R&D returns, promise to heighten biopharma interest in tapping into the potential of SkySTAR and other platforms

08 November 2019

Catch up on the most important life sciences IP developments from the past month

Read our most recent monthly round-up for key pharma and biotech IP stories from October 2019

01 November 2019

<em>Unwired Planet</em> and <em>Conversant</em> decisions likely to stand, which leaves Huawei and ZTE with big calls to make

The justices hearing the much-watched UK Supreme Court FRAND licensing appeals did not seem disposed to reverse, but that may not be the end of the story

25 October 2019

GlobalFoundries’ patent attack on TSMC may have come too late  

In-depth analysis shows that the Taiwanese semiconductor business has not only bulked up its portfolio over the last decade, but also considerably improved its quality

25 October 2019

UK Supreme Court hands employee-inventor a dramatic £2 million victory

Judgment vindicates professor’s 20-year fight for share of Unilever licensing profit and looks set to reshape British law on employee compensation for inventions

09 October 2019

IBM has the world's most valuable patent portfolio, new analysis claims

Samsung, Canon, Microsoft and Bosch round-out the top five who, between them, are said to own assets worth well in excess of $35 billion

23 September 2019

Nanjing judge sets Chinese SEP rate in dispute between Conversant and Huawei

Chinese court has had its say on royalties - and it looks like the telecoms giant has got exactly what it was looking for

26 August 2019

Three key IP takeaways from Bayer's $7.6 billion sale of its animal health unit

The German company's divestiture to Elanco is the latest example of a pharma giant fleeing non-core business areas - and it is unlikely to be the last

19 July 2019

Alphabet is trimming down its portfolio - but only after sustained growth  

The tech giant saw a steep drop in the number of US patents granted in 2018 after having spent years building its portfolio organically and through strategic acquisitions